Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2

Journal of Immunology

Volumn 171, Issue 2, 2003, Pages 995-1000

  Chabot, Sophie ^a   Koumanov, Kamen ^b   Lambeau, Gérard ^c   Gelb, Michael H ^d   Balloy, Viviane ^a   Chignard, Michel ^a   Whitsett, Jeffrey A ^e   Touqui, Lhousseine ^a,f  

^a INSTITUT PASTEUR   (France)

^b Faculte de Medecine St Antoine   (France)

^c CNRS   (France)

^d UNIVERSITY OF WASHINGTON   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 IIA; PHOSPHOLIPASE A2 IIC; PHOSPHOLIPASE A2 IID; PHOSPHOLIPASE A2 IIE; PHOSPHOLIPASE A2 IIF; PHOSPHOLIPID; SURFACTANT; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE TARGETING; HYDROLYSIS; INFLAMMATION; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

EID: 0037771393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.2.995     Document Type: Article

References (48)

1. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342:1334.
2. Dobbs, L. G. 1989. Pulmonary surfactant. Annu. Rev. Med. 40:431.
3. Holm, B. A., L. Keicher, M. Y. Liu, J. Sokolowski, and G. Enhorning. 1991. Inhibition of pulmonary surfactant function by phospholipases. J. Appl. Physiol. 71:317.
4. 2 in ARDS pathogenesis. Mol. Med. Today 5:244.
5. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488:1.
6. 2 and their receptors and binding proteins. Biochim. Biophys. Acta 1488:59.
7. 2. J. Biochem. 131:285.
8. 2 with homology to the group III bee venom enzyme. J. Biol. Chem. 275:7492.
9. 2. J. Biol. Chem. 274:19152.
10. 2: cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J. Biol. Chem. 274:31195.
11. 2. J. Biol. Chem. 272:15745.
12. 2. J. Biol. Chem. 275:39823.
13. 2 activities are increased in human adult respiratory distress syndrome. Am. J. Physiol. 269: L109.
14. 2 protein interaction. J. Clin. Invest. 102:1152.
15. Baker, C. S., T. W. Evans, B. J. Randle, and P. L. Haslam. 1999. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 353: 1232.
16. Kuroki, Y., and D. R. Voelker. 1994. Pulmonary surfactant proteins. J. Biol. Chem. 269:25943.
17. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler III, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976.
18. Gunther, A., C. Siebert, R. Schmidt, S. Ziegler, F. Grimminger, M. Yabut, B. Temmesfeld, D. Walmrath, H. Morr, and W. Seeger. 1996. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 153:176.
19. Veldhuizen, R. A., L. A. McCaig, T. Akino, and J. F. Lewis. 1995. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 132:1867.
20. Korfhagen, T. R., M. D. Bruno, G. F. Ross, K. M. Huelsman, M. Ikegami, A. H. Jobe, S. E. Wert, B. R. Stripp, R. E. Morris, S. W. Glasser, et al. 1996. Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 93:9594.
21. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713.
22. 2 in alveolar macrophages: down-regulation by an inflammatory signal. J. Biol. Chem. 270:17327.
23. 2. J. Biol. Chem. 277:48535.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
25. 2 in human leukemia cell lines: its implication for intracellular signaling. Proc. Natl. Acad. Sci. USA 91:6274.
26. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911.
27. Böttcher, C. J. F., C. M. van Gent, and C. Pries. 1961. A rapid and sensitive sub-microphosphorus detrermination. Anal. Clin. Acta. 24:203.
28. Huffman, J. A., W. M. Hull, G. Dranoff, R. C. Mulligan, and J. A. Whitsett. 1996. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 97:649.
29. Ikegami, M., T. R. Korfhagen, J. A. Whitsett, M. D. Bruno, S. E. Wert, K. Wada, and A. H. Jobe. 1998. Characteristics of surfactant from SP-A-deficient mice. Am. J. Physiol. 275:L247.
30. 2 for phosphatidic acid. Biochem. J. 321:737.
31. 2 action toward mixed micelles of detergent and phospholipids. Adv. Exp. Med. Biol. 101:165.
32. Waite, M. 1990. Phospholipases, enzymes that share a substrate class. Adv. Exp. Med. Biol. 279:1.
33. 2-paradigm. Chem. Rev. 101:2613.
34. 2 are natural ligands of the mouse 180-kDa M-type receptor. J. Biol. Chem. 274:7043.
35. 2 on their M-type 180-kDa membrane receptor. J. Biol. Chem. 270:28869.
36. 2 receptor. FEBS Lett. 478:187.
37. Haagsman, H. P., S. Hawgood, T. Sargeant, D. Buckley, R. T. White, K. Drickamer, and B. J. Benson. 1987. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J. Biol. Chem. 262: 13877.
38. 2. Biochemistry 34:13146.
39. 2-induced pathophysiologic changes in the guinea pig lung. Am. J. Pathol. 136:1283.
40. 2: structural and functional changes. Am. Rev. Respir. Dis. 143:1102.
41. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275:3179.
42. 2 with phosphatidylcholine-phosphatidylglycerol mixed lipids. Biochemistry 39:9623.
43. Hallman, M., R. Spragg, J. H. Harrell, K. M. Moser, and L. Gluck. 1982. Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest. 70:673.
44. Pison, U., W. Seeger, R. Buchhorn, T. Joka, M. Brand, U. Obertacke, H. Neuhof, and K. P. Schmit-Neuerburg. 1989. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 140:1033.
45. 2-mediated phosphatidylglycerol deficiency predicts surfactant dysfunction in asthma. Am. J. Respir. Crit. Care Med. 163:733a (Abstr.).
46. Jacob, J., M. Hallman, and L. Gluck. 1980. Phosphatidylinositol and phosphatidylglycerol enhance surface active properties of lecithin. Pediatr. Res. 14:644a (Abstr.).
47. Bangham, A. D., C. J. Moley, and M. C. Phillips. 1979. The physical properties of an effective lung surfactant. Biochim. Biophys. Acta. 573:552.
48. Lewis. J. F., M. Ikegami, A. H. Jobe, and D. Absolom. 1993. Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am. Rev. Respir. Dis. 147:1364.